Medical News

RSS
Novocell is now ViaCyte

Novocell is now ViaCyte

GeoVax Labs reports net loss of $690,789 for first-quarter 2010

GeoVax Labs reports net loss of $690,789 for first-quarter 2010

Forward's second-quarter gross profit up 50%

Forward's second-quarter gross profit up 50%

Use of combined PET/CT can confirm suspected colorectal cancer recurrence at early stage: Study

Use of combined PET/CT can confirm suspected colorectal cancer recurrence at early stage: Study

GOP's 'repeal health law' strategy may backfire in general election

GOP's 'repeal health law' strategy may backfire in general election

Varying portion size may encourage children to eat more fruits and vegetables

Varying portion size may encourage children to eat more fruits and vegetables

Endo Pharmaceuticals signs agreement to acquire HealthTronics

Endo Pharmaceuticals signs agreement to acquire HealthTronics

BioScrip, drugstore.com form strategic partnership

BioScrip, drugstore.com form strategic partnership

Book excerpt -- Landmark: The Inside Story of America's New Health Care Law and What It Means for Us All

Book excerpt -- Landmark: The Inside Story of America's New Health Care Law and What It Means for Us All

DexCom first-quarter product revenue up 153%

DexCom first-quarter product revenue up 153%

Update on CEL-SCI's Phase III clinical trial of Multikine

Update on CEL-SCI's Phase III clinical trial of Multikine

Study finds medical homes help lower health care costs, maintain quality

Study finds medical homes help lower health care costs, maintain quality

Cardiogenesis reports 13% increase in first-quarter 2010 revenue

Cardiogenesis reports 13% increase in first-quarter 2010 revenue

ArthroCare reports total revenue of $90.6M for first-quarter 2010

ArthroCare reports total revenue of $90.6M for first-quarter 2010

African lawmakers appeal for U.N. resolution banning female genital mutilation

African lawmakers appeal for U.N. resolution banning female genital mutilation

Allos Therapeutics reports net loss of $20.5 million for first-quarter 2010

Allos Therapeutics reports net loss of $20.5 million for first-quarter 2010

New research suggests tPA can act as neuroprotectant against stroke

New research suggests tPA can act as neuroprotectant against stroke

C. R. Bard reaches definitive agreement to acquire SenoRx

C. R. Bard reaches definitive agreement to acquire SenoRx

FDA approves Provenge for treating men with advanced prostate cancer

FDA approves Provenge for treating men with advanced prostate cancer

Democrat endorses GOP plan on hospital price disclosure

Democrat endorses GOP plan on hospital price disclosure

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.